홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
ESLA
#3530
Estrella Immunopharma, Inc. Common Stock
1.2
2
+0.83%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
+0.83%
월간 변동
+10.91%
6달 변화
+29.79%
년간 변동율
+25.77%
이전 종가
1.2
1
Open
1.2
2
Bid
Ask
Low
1.2
2
High
1.2
2
양
1
마켓
주식
헬스케어
ESLA
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
Q1, 25
Q2, 25
Q3, 25
Total assets
2.44 M
2.98 M
3.52 M
Total liabilities
4.28 M
9.08 M
13.36 M
Total equity
-1.83 M
-6.09 M
-9.84 M
Total liabilities & shareholders' equities
2.44 M
2.98 M
3.52 M
Total debt
—
—
—
Net debt
—
—
—
뉴스
Estrella annonce un taux de réponse complète de 100% dans son essai sur le lymphome
Estrella reports 100% complete response rate in lymphoma trial
Estrella présentera des données de phase 1 sur sa thérapie cellulaire ciblant CD19
Estrella to present phase 1 data on CD19-targeted cell therapy
Estrella Immunopharma reçoit un avis du Nasdaq pour retard de son assemblée annuelle
Estrella Immunopharma receives Nasdaq notice for delayed annual meeting
Estrella Immunopharma clôture une offre directe enregistrée de 8 millions $
Estrella Immunopharma closes $8 million registered direct offering
Le titre de l’action Estrella Immunopharma chute après l’annonce d’une offre de 8 millions $
Estrella Immunopharma stock falls after announcing $8 million offering
Estrella Immunopharma lève 8 millions de dollars via une offre enregistrée
Estrella Immunopharma raises $8 million through registered offering